GH 3D: breakout forming inside ascending channelThe price of GH continues consolidating within the top of an ascending channel, confirming bullish structure. The rectangular accumulation has lasted for over three months, with price staying above all major EMAs and MAs - a strong trend confirmation. On the last impulse, volume increased, and now the price is compressing again. A breakout with a retest would serve as a valid entry. First target lies near 61.38, second at 73.66, and third at 87.37 - aligned with the upper range of the medium-term Fibonacci extension. Fundamentally, GH remains a promising biotech pick amid sector rotation and potential Fed easing. EMAs and MAs sit below price, and D/A supports the breakout scenario. Waiting for confirmation before entering.
GH
A stock with a higher price to earnings ratio than Shopify? I'm sure this company has a lot of really compelling reasons why they're going to make their valuation make sense at some point in the future but right now the company is worth 67% more than $SHOP which is arguably the most overvalued stock with a market cap above a billion. My guess is we test $60 soon, bounce off $60 to around $65 and then proceed lower possibly all the way to $45. The company is raising guidance, but there is incredible uncertainty regarding their value proposition. We recently breached a volume support level at $75. Buyers are exhausted. Another scenario: we could bounce off the $70 level but then quickly move lower directly to $50. I'm 70% sure this stock will be at least 20% lower in the next three months.